Clinical trial
Stem Cell Transplant for Patients With Blood Malignancy Using Donors and Less…
NCT00048412 · Baylor College of Medicine, Other · Completed
Key facts
| NCT number | NCT00048412 |
|---|---|
| Title | Stem Cell Transplant for Patients With Blood Malignancy Using Donors and Less Toxic Chemotherapy With CAMPATH 1H |
| Official title | Phase I/II Study of Allogeneic Stem Cell Transplantation for Patients With Hematologic Malignancy, Using MHC Identical or Near Identical Donors and Sub-Myeloablative Conditioning With CAMPATH 1H (DIMSUM) |
| Lead sponsor | Baylor College of Medicine, Other |
| Collaborators | The Methodist Hospital Research Institute Center for Cell and Gene Therapy, Baylor College of Medicine |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Myelodysplastic Disorders, Leukemia, Multiple Myeloma, Plasma Cell Dyscrasia, Lymphoproliferative Disorders |
| Intervention type | Drug, Procedure |
| Interventions | FLUDARABINE, CAMPATH 1H, FK50, Stem Cell Collection and Infusion |
| Enrollment | 40 |
| Start date | Jun 1, 2000 |
| Primary completion | Nov 12, 2004 |
| Completion | Nov 12, 2004 |
| First posted | Nov 1, 2002 |
| Last update posted | Jan 18, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: